Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Clinical trial NCT01359956 · COMPLETED

Trial details

NCT number: NCT01359956
Sponsor: National Cancer Institute, Naples
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma Recurrent Melanoma

Start date: 2002-04-01
Primary completion: 2011-02-01
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.